is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to [Limited Offer] GIP / GLP-1
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to [Limited Offer] GIP / GLP-1](https://www.luxora.shop/cdn/shop/files/Gemini_Generated_Image_p756i4p756i4p756.png?v=1775532162&width=480)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to [Limited Offer] GIP / GLP-1](https://i.abcnewsfe.com/a/ed9f4811-7c11-41e9-85b2-efa2fc8004b7/weight-loss-drugs-mounjaro-gty-bh-251130_1764523075114_hpMain_16x9.jpg?w=992)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to [Limited Offer] GIP / GLP-1](https://media.post.rvohealth.io/wp-content/uploads/2026/06/GLP1_Roundup-header-1296x728-2.jpg)
![is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to [Limited Offer] GIP / GLP-1](https://xtalks.com/wp-content/uploads/2022/11/Mounjaro-vs-Ozempic-2-1024x576.png)






















